WHO chief scientist welcomes India’s decision to restart COVID-19 vaccine exports

New Delhi: Chief scientist of World Health Organization (WHO) Dr Soumya Swaminathan on Tuesday welcomed India’s decision to restart COVID-19 vaccine exports. She said that the decision will go long way to achieve global Vaccine Equity.

“COVAX welcomes the decision to restart Covid vaccine exports. Will go a long way to achieve global Vaccine Equity,” Soumya Swaminathan said in a tweet.

Union Minister of Health and Family Welfare Mansukh Mandaviya on Monday announced that in the fourth quarter this year, the Government of India will resume Vaccine Maitri, an initiative to provide Covid vaccines to countries around the world and also fulfil its responsibility under Covax.

“Under Vaccine Maitri, we will help the world and contribute to Covax in the fourth quarter,” Mandaviya said to reporters. He also announced that next month government is expecting more than 30 crore doses from vaccine manufacturers.

Health Minister estimated the target of the fourth quarter this year to be around 100 crores and highlighted that vaccination of own citizens is the topmost priority.

Meanwhile, with the administration of 96,46,778 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage exceeded 81.85 crores (81,85,13,827) as per provisional reports till 7 am on Tuesday, informed the Ministry of Health and Family Welfare.

The ministry said that this has been achieved through 80,35,135 sessions.

As per the data, as many as 1,03,69,386 healthcare workers have been inoculated with the first dose of COVID vaccine while 87,50,107 have been inoculated with both doses. The number of frontline workers vaccinated stands at 1,83,46,016 (first dose) and 1,45,66,593 (two doses).

Early this year, India halted vaccine exports as coronavirus cases surged in the country.

  • Related Posts

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    New Delhi:  Aurobindo Pharma Ltd on Tuesday said it has set April 23 as the opening date for its Rs 800 crore buyback offer. The closing date for the buyback…

    Boehringer Ingelheim launches AI centre for pharma research in London

    Bengaluru: German drugmaker Boehringer Ingelheim is launching a ​centre for artificial ​intelligence and machine learning in London, it said ​on Monday, as it seeks to expand its AI capabilities in…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Boehringer Ingelheim launches AI centre for pharma research in London

    Boehringer Ingelheim launches AI centre for pharma research in London

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid